venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $114,757 (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 65.8%

Value ($000) $75,492 Shares 4,289,304 Est. Cost $21.15 Unrealized -23.8%

HRMY HARMONY BIOSCIENCES HLDGS IN 13.5%

Value ($000) $15,459 Shares 489,194 Est. Cost $36.46 Unrealized -11.8%

ALMS ALUMIS INC 12.1%

Value ($000) $13,859 Shares 4,619,803 Est. Cost $9.90 Unrealized -52.3%

LYEL LYELL IMMUNOPHARMA INC 3.6%

Value ($000) $4,186 Shares 473,479 Est. Cost $9.11 Unrealized 0.0%

ALXO ALX ONCOLOGY HLDGS INC 3.5%

Value ($000) $4,026 Shares 9,699,925 Est. Cost $39.31 Unrealized -98.7%

ARTV ARTIVA BIOTHERAPEUTICS INC 1.5%

Value ($000) $1,735 Shares 1,148,975 Est. Cost $11.59 Unrealized -81.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	4,289,304	$75,492	65.8%	$21.15	-23.8%	COM	N69605108
HRMY	HARMONY BIOSCIENCES HLDGS IN	489,194	$15,459	13.5%	$36.46	-11.8%	COM	413197104
ALMS	ALUMIS INC	4,619,803	$13,859	12.1%	$9.90	-52.3%	COM	022307102
LYEL	LYELL IMMUNOPHARMA INC	473,479	$4,186	3.6%	$9.11	0.0%	COM NEW	55083R203
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$4,026	3.5%	$39.31	-98.7%	COM	00166B105
ARTV	ARTIVA BIOTHERAPEUTICS INC	1,148,975	$1,735	1.5%	$11.59	-81.9%	COM	04317A107